Discovery of a novel series of nonacidic benzofuran EP1 receptor antagonists

Abstract We describe the discovery and optimization of a novel series of benzofuran EP 1 antagonists, leading to the identification of 26d , a novel nonacidic EP 1 antagonist which demonstrated efficacy in preclinical models of chronic inflammatory pain.